Edinburgh, United Kingdom

Phillip Martin Cowley

USPTO Granted Patents = 11 

Average Co-Inventor Count = 3.8

ph-index = 2

Forward Citations = 15(Granted Patents)


Location History:

  • West Lothian, GB (2020)
  • Edinburgh, GB (2018 - 2021)

Company Filing History:


Years Active: 2018-2021

Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovations of Phillip Martin Cowley

Introduction

Phillip Martin Cowley is a notable inventor based in Edinburgh, GB. He has made significant contributions to the field of pharmaceuticals, holding a total of 11 patents. His work primarily focuses on inhibitors for specific enzymes that play a crucial role in various medical applications.

Latest Patents

Cowley's latest patents include a pharmaceutical compound that provides a tryptophan-2,3-dioxygenase (TDO) and/or indoleamine-2,3-dioxygenase (IDO) inhibitor. This compound is designed for use in medicine and comprises a complex formula that includes various organic groups and elements. Another significant patent involves substituted imidazopyridine compounds, which serve as inhibitors of IDO and TDO enzymes. These compounds are disclosed for their potential use in treating or preventing diseases associated with these enzymes.

Career Highlights

Throughout his career, Cowley has worked with prominent companies such as Iomet Pharma Ltd. and Merck Sharp & Dohme Corporation. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and patent development.

Collaborations

Cowley has collaborated with notable colleagues, including Alan Wise and Susan Davis. Their combined efforts have further advanced the research and development of innovative pharmaceutical solutions.

Conclusion

Phillip Martin Cowley is a distinguished inventor whose work in pharmaceuticals has led to significant advancements in medical treatments. His patents reflect a deep understanding of complex biochemical processes and a commitment to improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…